Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
In recent years, much research has been focused on the field of adoptive cell therapies (ACT) that use native or genetically modified T cells as therapeutic tools. Immunotherapy with T cells expressing chimeric antigen receptors (CARs) demonstrated great success in the treatment of haematologic mali...
Main Authors: | Elżbieta Chruściel, Zuzanna Urban-Wójciuk, Łukasz Arcimowicz, Małgorzata Kurkowiak, Jacek Kowalski, Mateusz Gliwiński, Tomasz Marjański, Witold Rzyman, Wojciech Biernat, Rafał Dziadziuszko, Carla Montesano, Roberta Bernardini, Natalia Marek-Trzonkowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/683 |
Similar Items
-
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01) -
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires
by: Corinna Grunert, et al.
Published: (2022-04-01) -
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
by: Else M. Inderberg, et al.
Published: (2017-04-01) -
Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer
by: Shuen-Iu Hung, et al.
Published: (2023-12-01) -
Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering
by: Masahiro Okada, et al.
Published: (2023-06-01)